This Is MS Multiple Sclerosis Community: Knowledge & Support

http://www.reuters.com/article/Health09 ... WY20091109

excerpt from the above article

Jimenez said the lower dose of oral multiple sclerosis drug FTY720, which Novartis plans to file with regulators next month, was "clearly approvable" and would be an attractive option for patients seeking an alternative to injections.

It is in a head-to-head race with Merck KGaA's (MRCG.DE: Quote, Profile, Research, Stock Buzz) cladribine to be the first oral MS drug on the market and the German group has stolen a march having already filed for approval in the United States.

TOL

What are the release dates for these drugs? Did it say March for Cladribine? I couldn't tell when reading the link.

_________________
Take care, Ewizabeth Previously Avonex, Rebif & Copaxone RRMS ~Tysabri, 31 infusions, ended 9/09. Starting Copaxone 12/09, waiting for Cladribine to be approved in 2010.

Sorry...it wasn't clear to me either as to the actual date.

TOL

This is the one I'm sort of thinking about, so I was interested just in case you knew.

_________________
Take care, Ewizabeth Previously Avonex, Rebif & Copaxone RRMS ~Tysabri, 31 infusions, ended 9/09. Starting Copaxone 12/09, waiting for Cladribine to be approved in 2010.